-
-
Forbes Organoids Point The Way For Liver Regeneration (July 26, 2023)
A group of bioengineers led by Arnav Chhabra at the Massachusetts Institute of Technology have published a paper in the Proceedings of the National Academy of Sciences, detailing a new model of the liver. The microfluidic chip-based model allows researchers to understand the biological mechanisms underlying liver tissue regeneration and points to several molecules that may promote the process. The primary focus of the paper was in creating a liver model that incorporated three key features: hepatocytes, endothelial cells, and simulated blood flow.
STAT News European Commission accelerates phasing out animal testing, but stops short of a ban (July 26, 2023)
After months of deliberation, the European Commission has agreed to accelerate the phasing out of animal testing, but stopped short of a complete ban — drawing praise from university and industry groups but outrage from animal rights activists. The decision was made in response to a citizen’s initiative, which sought to strengthen an existing ban on animal testing in cosmetics that has been in effect for about a decade. The initiative also urged the European Union to avoid further animal testing requirements for chemicals and commit to legislation for creating a plan to phase out all animal testing before the end of the current legislative term.
The Statesman New placenta on a chip model to address preeclampsia in pregnancy (July 26, 2023)
Researchers have, in a breakthrough, developed a placenta on a chip that can potentially transform research into life-threatening conditions in pregnancy, such as preeclampsia caused by increased blood pressure. Named iPlacenta, the model developed by a team at University of Dundee in Scotland, can help examine the workings of placenta in 3D for the first time without increasing the risk to a mother or her foetus.
3D Printing Industry Researchers leverage MOIIN resins to evaluate microfluidics 3D printing for cell-based applications (July 24, 2023)
Researchers from Queensland University of Technology have conducted a case study to evaluate the use of 3D printing resins for the production of microfluidic components for cell-based applications. Ultimately the study, which was led by Louis Ong and Yi-Chin Toh, concluded that “with MOIIN High Temp and MOIIN Tech Clear, the 3D printing of microfluidic channels for cell-based applications are feasible. Both resins are observed to be biocompatible and highly amendable for microscopy imaging.”
-
- You must be logged in to reply to this topic.